Diabetes
Linatab M Tablet 2.5mg+1000mg
Out of Stock
Call for price
<h2> </h2><p>4 tablets</p><p>PRESENTATION</p><p>Linatab M 2.5/500: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 500 mg.</p><p>Linatab M 2.5/850: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 850 mg.</p><p>Linatab M 2.5/1000: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 1000 mg</p><p>DESCRIPTION</p><p>LINATAB M is a combination of 2 oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control in</p><p>patients with type-2 diabetes mellitus: Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor and Metformin, a member of the</p><p>biguanide class.</p><p>Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which exerts its action by slowing the inactivation of incretin</p><p>hormones</p>
4 tablets
PRESENTATION
Linatab M 2.5/500: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 500 mg.
Linatab M 2.5/850: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 850 mg.
Linatab M 2.5/1000: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 1000 mg
DESCRIPTION
LINATAB M is a combination of 2 oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control in
patients with type-2 diabetes mellitus: Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor and Metformin, a member of the
biguanide class.
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which exerts its action by slowing the inactivation of incretin
hormones
No additional specifications available.
No vendor information available.